Document detail
ID

oai:pubmedcentral.nih.gov:7643...

Topic
Research Articles
Author
Tsunemi, Taiji Ishiguro, Yuta Yoroisaka, Asako Valdez, Clarissa Miyamoto, Kengo Ishikawa, Keiichi Saiki, Shinji Akamatsu, Wado Hattori, Nobutaka Krainc, Dimitri
Langue
en
Editor

Society for Neuroscience

Category

The Journal of Neuroscience

Year

2020

listing date

12/12/2022

Keywords
lysosomal dopaminergic function parkinson α-synuclein atp13a2
Metrics

Abstract

The pathologic hallmark of Parkinson's disease is the accumulation of α-synuclein-containing Lewy bodies/neurites almost exclusively in neurons, and rarely in glial cells.

However, emerging evidence suggests that glia such as astrocytes play an important role in the development of α-synuclein pathology.

Using induced pluripotent stem-derived dopaminergic neurons and astrocytes from healthy subjects and patients carrying mutations in lysosomal ATP13A2, a monogenic form of synucleinopathy, we found that astrocytes rapidly internalized α-synuclein, and exhibited higher lysosomal degradation rates compared with neurons.

Moreover, coculturing astrocytes and neurons led to decreased accumulation of α-synuclein in neurons and consequently diminished interneuronal transfer of α-synuclein.

These protective functions of astrocytes were attenuated by ATP13A2 deficiency, suggesting that the loss of ATP13A2 function in astrocytes at least partially contributes to neuronal α-synuclein pathology.

Together, our results highlight the importance of lysosomal function in astrocytes in the pathogenesis of synucleinopathies.

SIGNIFICANCE STATEMENT While most neurodegenerative disorders are characterized by the accumulation of aggregated mutant proteins exclusively in neurons, the contribution of glial cells in this process remains poorly explored.

Here, we demonstrate that astrocytes contribute to the removal of extracellular α-synuclein and that disruption of this pathway caused by mutations in the Parkinson's disease-linked gene ATP13A2 result in α-synuclein accumulation in human dopaminergic neurons.

We found that astrocytes also protect neurons from α-synuclein propagation, whereas ATP13A2 deficiency in astrocytes compromises this protective function.

These results highlight astrocyte-mediated α-synuclein clearance as a potential therapeutic target in disorders characterized by the accumulation of α-synuclein, including Parkinson's disease.

Tsunemi, Taiji,Ishiguro, Yuta,Yoroisaka, Asako,Valdez, Clarissa,Miyamoto, Kengo,Ishikawa, Keiichi,Saiki, Shinji,Akamatsu, Wado,Hattori, Nobutaka,Krainc, Dimitri, 2020, Astrocytes Protect Human Dopaminergic Neurons from α-Synuclein Accumulation and Propagation, Society for Neuroscience

Document

Open Open

Share

Source

Articles recommended by ES/IODE AI

A rare case of localized peliosis hepatis during adjuvant chemotherapy including oxaliplatin mimicking a liver metastasis of colon cancer
peliosis hepatis metastatic liver tumor oxaliplatin oxaliplatin associated cancer metastatic tumor liver hepatis peliosis